ALNYLAM PHARMACEUTICALS, INC.·4

May 20, 4:07 PM ET

BRANDICOURT OLIVIER 4

4 · ALNYLAM PHARMACEUTICALS, INC. · Filed May 20, 2022

Insider Transaction Report

Form 4
Period: 2022-05-18
Transactions
  • Award

    Stock Option (right to buy)

    2022-05-18+5,1535,153 total
    Exercise: $128.31From: 2023-05-18Exp: 2032-05-17Common Stock (5,153 underlying)
Footnotes (1)
  • [F1]This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT